Hemogenyx Pharmaceuticals (HEMO) Stock Chart & Stock Price History GBX 1.32 -0.02 (-1.49%) (As of 11/1/2024 ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlines Hemogenyx Pharmaceuticals Stock Price Performance5 Day Performance-1.12%1 Month Performance-15.82%3 Month Performance+3.03%6 Month Performance-15.44%Year-To-Date Performance-42.39%1 Year Performance-38.37% Receive HEMO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hemogenyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Chaikin AnalyticsSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's what that means for your money. Billionaire Wall Street investors are quietly offloading millions of shares. What do they know that you don't? It's arguably the most popular stock in the world. Now, one 50-year Wall Street legend says its day in the sun could finally be coming to an end. Last year, he warned of two stocks that went on to crash 60%.Now he's just issued a warning for the most popular stock in the world: Nvidia (NVDA). HEMO Stock Chart for Saturday, November, 2, 2024 HEMO Chart by TradingView Hemogenyx Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/01/2024GBX 1.34GBX 1.34-0.30%GBX 1.40GBX 1.302.13 million shs£17.90 million10/31/2024GBX 1.39GBX 1.34-3.60%GBX 1.40GBX 1.301.17 million shs£17.96 million10/30/2024GBX 1.34GBX 1.39+3.89%GBX 1.59GBX 1.307.57 million shs£18.63 million10/29/2024GBX 1.34GBX 1.34-0.15%GBX 1.42GBX 1.3011.90 million shs£17.93 million10/28/2024GBX 1.49GBX 1.34-10.07%GBX 1.58GBX 1.3412.14 million shs£17.96 million10/25/2024GBX 1.29GBX 1.49+15.68%GBX 1.51GBX 1.307.95 million shs£19.97 million Get the Latest News and Ratings for HEMO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hemogenyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 10/24/2024GBX 1.19GBX 1.29+8.24%GBX 1.34GBX 1.107.30 million shs£17.26 million10/23/2024GBX 1.38GBX 1.19-13.52%GBX 1.40GBX 1.199.24 million shs£15.95 million10/22/2024GBX 1.38GBX 1.38-0.58%GBX 1.47GBX 1.349.73 million shs£18.44 million10/21/2024GBX 1.41GBX 1.38-1.91%GBX 1.55GBX 1.3214.20 million shs£18.55 million10/18/2024GBX 1.13GBX 1.41+25.09%GBX 1.60GBX 1.0850.05 million shs£18.91 million10/17/2024GBX 1.17GBX 1.13-3.84%GBX 1.17GBX 1.099.54 million shs£15.12 million10/16/2024GBX 1.15GBX 1.17+2.45%GBX 1.24GBX 1.1121.51 million shs£15.72 million10/15/2024GBX 1.17GBX 1.15-2.14%GBX 1.20GBX 1.1022.28 million shs£15.34 million10/14/2024GBX 1.30GBX 1.17-9.93%GBX 1.30GBX 1.1229.51 million shs£15.68 million10/11/2024GBX 1.30GBX 1.24-4.02%GBX 1.35GBX 1.242.41 million shs£16.66 million10/10/2024GBX 1.28GBX 1.30+1.17%GBX 1.35GBX 1.255.94 million shs£17.35 million10/09/2024GBX 1.30GBX 1.28-1.54%GBX 1.35GBX 1.205.09 million shs£17.15 million10/08/2024GBX 1.32GBX 1.30-1.52%GBX 1.35GBX 1.2311.01 million shs£17.42 million10/07/2024GBX 1.48GBX 1.32-10.75%GBX 1.45GBX 1.2724.89 million shs£17.69 million10/04/2024GBX 1.50GBX 1.48-1.14%GBX 1.64GBX 1.455.16 million shs£19.82 million10/03/2024GBX 1.57GBX 1.50-4.96%GBX 1.70GBX 1.4518.74 million shs£20.05 million10/02/2024GBX 1.56GBX 1.57+1.09%GBX 3GBX 1.5044.82 million shs£21.09 million10/01/2024GBX 1.65GBX 1.56-5.35%GBX 1.70GBX 1.551.80 million shs£20.86 million09/30/2024GBX 1.62GBX 1.65+1.79%GBX 1.70GBX 1.556.93 million shs£22.04 million09/27/2024GBX 1.75GBX 1.62-7.66%GBX 1.70GBX 1.3020.34 million shs£21.65 million09/26/2024GBX 1.67GBX 1.75+4.98%GBX 1.80GBX 1.6514.11 million shs£23.45 million09/25/2024GBX 1.57GBX 1.67+5.91%GBX 1.80GBX 1.5518.10 million shs£22.34 million09/24/2024GBX 1.49GBX 1.57+5.92%GBX 1.60GBX 1.506.89 million shs£21.09 million09/23/2024GBX 1.47GBX 1.49+0.81%GBX 1.60GBX 1.494.40 million shs£19.91 million09/20/2024GBX 1.46GBX 1.47+0.96%GBX 1.50GBX 1.442.26 million shs£19.75 million09/19/2024GBX 1.47GBX 1.46-0.54%GBX 1.46GBX 1.424.87 million shs£19.56 million09/18/2024GBX 1.52GBX 1.47-3.17%GBX 1.53GBX 1.429.53 million shs£19.67 million09/17/2024GBX 1.58GBX 1.52-4.23%GBX 1.60GBX 1.514.10 million shs£20.31 million09/16/2024GBX 1.68GBX 1.58-5.55%GBX 1.80GBX 1.556.68 million shs£21.21 million09/13/2024GBX 1.60GBX 1.68+4.75%GBX 1.80GBX 1.5618.37 million shs£22.46 million09/12/2024GBX 1.33GBX 1.60+20.12%GBX 1.65GBX 1.3523.12 million shs£21.44 million09/11/2024GBX 1.34GBX 1.33-0.75%GBX 1.36GBX 1.304.89 million shs£17.85 million09/10/2024GBX 1.35GBX 1.34-0.45%GBX 1.35GBX 1.283.95 million shs£17.98 million09/09/2024GBX 1.30GBX 1.35+3.77%GBX 1.40GBX 1.255.36 million shs£18.06 millionSell NVDA Now? (Ad)Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's what that means for your money. Billionaire Wall Street investors are quietly offloading millions of shares. What do they know that you don't? It's arguably the most popular stock in the world. Now, one 50-year Wall Street legend says its day in the sun could finally be coming to an end. Last year, he warned of two stocks that went on to crash 60%.Now he's just issued a warning for the most popular stock in the world: Nvidia (NVDA).09/06/2024GBX 1.28GBX 1.25-2.50%GBX 1.33GBX 1.251.37 million shs£16.75 million09/05/2024GBX 1.36GBX 1.28-5.60%GBX 1.37GBX 1.281.45 million shs£17.18 million09/04/2024GBX 1.31GBX 1.36+4.06%GBX 1.36GBX 1.284.12 million shs£18.20 million09/03/2024GBX 1.31GBX 1.31-0.38%GBX 1.40GBX 1.311.48 million shs£17.49 million09/02/2024GBX 1.31GBX 1.31+0.08%GBX 1.34GBX 1.2710.83 million shs£17.55 million08/30/2024GBX 1.30GBX 1.27-1.93%GBX 1.35GBX 1.273.88 million shs£17.03 million08/29/2024GBX 1.27GBX 1.30+1.81%GBX 1.30GBX 1.273.30 million shs£17.37 million08/28/2024GBX 1.31GBX 1.27-2.75%GBX 1.35GBX 1.271.90 million shs£17.06 million08/27/2024GBX 1.31GBX 1.31-0.30%GBX 1.35GBX 1.271.19 million shs£17.54 million08/26/2024GBX 1.29GBX 1.31+1.47%GBX 1.35GBX 1.253.04 million shs£17.59 million08/23/2024GBX 1.30GBX 1.31+1.00%GBX 1.35GBX 1.253.04 million shs£17.59 million08/22/2024GBX 1.32GBX 1.30-1.59%GBX 1.40GBX 1.301.28 million shs£17.42 million08/21/2024GBX 1.37GBX 1.32-3.51%GBX 1.40GBX 1.322.31 million shs£17.70 million08/20/2024GBX 1.38GBX 1.37-0.65%GBX 1.45GBX 1.322.97 million shs£18.35 million08/19/2024GBX 1.38GBX 1.38-0.29%GBX 1.40GBX 1.352.33 million shs£18.47 million08/16/2024GBX 1.37GBX 1.40+2.34%GBX 1.40GBX 1.356.35 million shs£18.76 million08/15/2024GBX 1.32GBX 1.37+3.95%GBX 1.37GBX 1.302.68 million shs£18.33 million08/14/2024GBX 1.30GBX 1.32+1.00%GBX 1.33GBX 1.273.26 million shs£17.63 million08/13/2024GBX 1.23GBX 1.30+5.59%GBX 1.32GBX 1.2010.47 million shs£17.46 million08/12/2024GBX 1.27GBX 1.23-3.14%GBX 1.30GBX 1.231.59 million shs£16.54 million08/09/2024GBX 1.27GBX 1.27-0.08%GBX 1.27GBX 1.24874,308 shs£17.06 million08/08/2024GBX 1.27GBX 1.27+0.31%GBX 1.30GBX 1.251.19 million shs£17.07 million08/07/2024GBX 1.27GBX 1.27GBX 1.30GBX 1.24646,409 shs£17.02 million08/06/2024GBX 1.22GBX 1.27+3.84%GBX 1.30GBX 1.174.96 million shs£17.02 million08/05/2024GBX 1.28GBX 1.22-4.08%GBX 1.27GBX 1.165.57 million shs£16.39 million08/02/2024GBX 1.28GBX 1.29+0.55%GBX 1.30GBX 1.251.31 million shs£17.23 million08/01/2024GBX 1.31GBX 1.28-1.99%GBX 1.35GBX 1.253.81 million shs£17.14 million Related Companies e-therapeutics Stock Price Chart SkinBioTherapeutics Stock Price Chart Tissue Regenix Group Stock Price Chart Poolbeg Pharma Stock Price Chart Arecor Therapeutics Stock Price Chart Sareum Stock Price Chart Ondine Biomedical Stock Price Chart NetScientific Stock Price Chart Oncimmune Stock Price Chart OptiBiotix Health Stock Price Chart Receive HEMO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hemogenyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (LON:HEMO) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hemogenyx Pharmaceuticals Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Hemogenyx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
